Women’s Health
Enroll in Endometrial Hyperplasia Clinical Trials Focused on Advancing Non-Surgical Treatment Options
NAEH Clinical Research
Nonatypical Endometrial Hyperplasia Clinical Trials
Nonatypical endometrial hyperplasia (NAEH) is a condition where the lining of the uterus becomes abnormally thick, most often due to hormonal imbalances. While not cancerous, it is not a condition to leave unmanaged. Without treatment, it can progress. And yet, despite how common it is, there are currently no approved treatments for NAEH, leaving many women without a clear, evidence-backed path forward.
Zillan Clinical Research is conducting endometrial hyperplasia research study in as part of a Phase III, multi-center study evaluating whether a hormone-releasing intrauterine device. already widely used for birth control, can safely and effectively restore the uterine lining to normal in women diagnosed with NAEH.
Discovering a Targeted Treatment Path for Nonatypical Endometrial Hyperplasia
For many women, abnormal uterine bleeding and hormonal imbalances can be frustrating, disruptive, and difficult to manage. Nonatypical Endometrial Hyperplasia (NAEH) can affect daily life and may require ongoing medical care.
The endometrial hyperplasia clinical trials at Zillan Clinical Research are evaluating a study device, which works by gradually releasing progesterone locally within the uterus to help rebalance hormone levels and restore normal uterine lining. Participants are randomly assigned in a 2:1 ratio to receive either study device treatment group or oral therapy for 6 months. Each participant will be in the study for approximately 10 months, with up to 5 clinic visits, one before treatment, three during, and one after, with all study-related care provided free of cost.
Now Enrolling
Nonatypical Endometrial Hyperplasia (NAEH)
Why Patients Trust Us
At Zillan Clinical Research, we combine compassionate patient care with rigorous clinical research standards to help advance innovative treatments for women’s health conditions.
High Investigator Involvement
Providing direct physician oversight from enrollment through study completion.
Phase I–IV Research Expertise
Conducting advanced clinical studies with a focus on safety, quality, and scientific excellence.
Quality First Culture
Maintaining strict research standards that prioritize participant well-being and reliable study outcomes.
Global Research Partnerships
Working alongside leading pharmaceutical and biotechnology organizations to advance women’s healthcare.
Participant-Focused Experience
Ensuring every participant receives clear communication, guidance, and support throughout the study journey.
Innovation
Supporting advanced research approaches that drive medical progress
FAQ
Frequently Asked Questions
Join Us